In the clinical realm of memory care, pharmacy and pharmacology have never been under greater scrutiny given new guidelines from the Centers for Medicare and Medicaid Services (CMS) to ensure appropriate medication use.  Organizations can be at great risk from both a regulatory and legal perspective from inappropriate medication therapy and their associated medication-related problems.  But, true medication management takes a team, and clinical team collaboration is undoubtedly at the center of success.

 

This session features the President of the American Society of Consultant Pharmacists (ASCP), Joseph G. Marek, as he defines a model for effective medication therapy management between physicians, the facility care team and pharmacists that ultimately will prevent or reduce potential legal risks, improve quality measures, improve clinical outcomes and reduce overall costs for both the skilled nursing and assisted living organizations.  Join Marek, as he reviews not only the top prescription medications used in memory care (Donepezil, Rivastigmine, Galantamine, Memantine, etc.), but also other non-memory care medications that can cause medication-related problems in residents with dementia —ultimately relating to how these can impact their overall quality of life.  Through a collaborative team approach an individual residents’ medication regimen can be effectively managed and optimized.
 
Learning Objectives: